Mikhail M. Kostik

1.6k total citations
128 papers, 668 citations indexed

About

Mikhail M. Kostik is a scholar working on Rheumatology, Hematology and Surgery. According to data from OpenAlex, Mikhail M. Kostik has authored 128 papers receiving a total of 668 indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Rheumatology, 47 papers in Hematology and 34 papers in Surgery. Recurrent topics in Mikhail M. Kostik's work include Autoimmune and Inflammatory Disorders Research (47 papers), Inflammasome and immune disorders (21 papers) and Adolescent and Pediatric Healthcare (19 papers). Mikhail M. Kostik is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (47 papers), Inflammasome and immune disorders (21 papers) and Adolescent and Pediatric Healthcare (19 papers). Mikhail M. Kostik collaborates with scholars based in Russia, United States and Italy. Mikhail M. Kostik's co-authors include Vyacheslav Chasnyk, Angelo Ravelli, Evgeny N. Suspitsin, Ekaterina Kuchinskaya, María Isabel González, Angela Pistorio, Alberto Martini, Marek Böhm, Charalampia Papadopoulou and Randy Q. Cron and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Clinical Endocrinology & Metabolism and Annals of the Rheumatic Diseases.

In The Last Decade

Mikhail M. Kostik

97 papers receiving 641 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikhail M. Kostik Russia 15 304 205 201 167 145 128 668
Denise Pires Marafon Italy 15 339 1.1× 250 1.2× 182 0.9× 162 1.0× 205 1.4× 39 741
Ryoki Hara Japan 14 269 0.9× 129 0.6× 175 0.9× 129 0.8× 167 1.2× 44 555
Luciana Breda Italy 17 421 1.4× 163 0.8× 306 1.5× 224 1.3× 252 1.7× 51 906
Jasmin Kümmerle‐Deschner Germany 13 222 0.7× 82 0.4× 196 1.0× 206 1.2× 194 1.3× 35 627
M. Gattinara Italy 15 576 1.9× 217 1.1× 303 1.5× 132 0.8× 123 0.8× 49 818
Ilaria Pagnini Italy 16 329 1.1× 88 0.4× 314 1.6× 282 1.7× 110 0.8× 50 773
R M Laxer Canada 16 369 1.2× 135 0.7× 354 1.8× 148 0.9× 140 1.0× 29 933
A M Prieur France 11 363 1.2× 153 0.7× 221 1.1× 231 1.4× 187 1.3× 17 649
Selcan Demir Türkiye 18 235 0.8× 222 1.1× 267 1.3× 375 2.2× 305 2.1× 71 925
Isabelle Melki France 15 156 0.5× 221 1.1× 268 1.3× 275 1.6× 285 2.0× 69 875

Countries citing papers authored by Mikhail M. Kostik

Since Specialization
Citations

This map shows the geographic impact of Mikhail M. Kostik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikhail M. Kostik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikhail M. Kostik more than expected).

Fields of papers citing papers by Mikhail M. Kostik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikhail M. Kostik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikhail M. Kostik. The network helps show where Mikhail M. Kostik may publish in the future.

Co-authorship network of co-authors of Mikhail M. Kostik

This figure shows the co-authorship network connecting the top 25 collaborators of Mikhail M. Kostik. A scholar is included among the top collaborators of Mikhail M. Kostik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikhail M. Kostik. Mikhail M. Kostik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Suspitsin, Evgeny N., et al.. (2024). IFN-I Score and Rare Genetic Variants in Children with Systemic Lupus Erythematosus. Biomedicines. 12(6). 1244–1244. 2 indexed citations
3.
Kostik, Mikhail M., et al.. (2024). Specific Features of Juvenile Idiopathic Arthritis Patients’ Cytokine Profile. Biomedicines. 12(1). 135–135. 2 indexed citations
4.
Chasnyk, Vyacheslav, et al.. (2024). Using HScore for Evaluation of Hemophagocytosis in Multisystem Inflammatory Syndrome Associated with COVID-19 in Children. Biomedicines. 12(2). 294–294. 2 indexed citations
5.
Chasnyk, Vyacheslav, et al.. (2023). Presence of uveitis as indicator of juvenile idiopathic arthritis severity: results of a retrospective cohort study. Pediatrician (St Petersburg). 14(2). 37–47. 1 indexed citations
6.
Kuchinskaya, Ekaterina, et al.. (2023). The experience of rituximab therapy in patients with juvenile systemic lupus erythematosus: the preliminary results of two-center cohort study. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 68(1). 74–84. 1 indexed citations
7.
Komissarov, Andrey B., et al.. (2023). COVID-19 Associated Vasculitis Confirmed by the Tissues RT-PCR: A Case Series Report. Biomedicines. 11(3). 870–870.
8.
Kostik, Mikhail M., et al.. (2023). Juvenile Dermatomyositis and Infantile Cerebral Palsy: Aicardi-Gouteres Syndrome, Type 5, with a Novel Mutation in SAMHD1—A Case Report. Biomedicines. 11(6). 1693–1693. 1 indexed citations
9.
Kostik, Mikhail M., et al.. (2023). Use of bisphosphonates in experimental bone tuberculous osteitis: CT imaging. SHILAP Revista de lepidopterología. 29(1). 78–84. 1 indexed citations
10.
Ward, Leanne M., Nathalie Alos, David A. Cabral, et al.. (2021). Zoledronic Acid vs Placebo in Pediatric Glucocorticoid-Induced Osteoporosis: A Randomized, Double-Blind, Phase 3 Trial. The Journal of Clinical Endocrinology & Metabolism. 106(12). e5222–e5235. 26 indexed citations
11.
Chasnyk, Vyacheslav, et al.. (2021). HEART INJURY IN PATIENTS WITH MULTISYSTEM INFLAMMATORY SYNDROME ASSOCIATED WITH SARS-CоV-2: A DESCRIPTION OF A SERIES OF CLINICAL CASES. PEDIATRIA Journal named after G N SPERANSKY. 100(5). 35–45. 3 indexed citations
12.
13.
Kostik, Mikhail M., et al.. (2018). ETANERCEPT TREATMENT RESULTS IN CHILDREN WITH NON-SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: REMISSION, RECRUDESCENCE, AND ADVERSE EVENTS. RETROSPECTIVE COHORT STUDY. Вопросы современной педиатрии. 17(2). 138–147. 1 indexed citations
14.
Vissarionov, Sergei V., et al.. (2017). The gene polymorphisms of COL1A1 and VDR in children with scoliosis. Pediatric Traumatology Orthopaedics and Reconstructive Surgery. 5(1). 5–12. 2 indexed citations
15.
Kostik, Mikhail M., et al.. (2017). The Use of Tocilizumab in 40 Patients With Polyarticular Juvenile Idiopathic Arthritis: the Results of a Retrospective Study. Вопросы современной педиатрии. 16(2). 148–155. 3 indexed citations
16.
17.
Kostik, Mikhail M., et al.. (2017). Primary idiopathic hypertrophic osteoarthropathy in a child: characteristics of the disease with a case report. Modern Rheumatology Journal. 11(4). 40–47.
18.
Kostik, Mikhail M., et al.. (2015). Use of Implantable Venous Port Systems in the Treatment of Children with Orphan Diseases (Mucopolysaccharidosis and Pompe Disease): Case Series. SHILAP Revista de lepidopterología. 14(4). 522–522. 1 indexed citations
19.
Kostik, Mikhail M., et al.. (2014). Role of vitamin D receptor (VDR) gene polymorphism in the pathogenesis of juvenile idiopathic arthritis: Theoretical and practical aspects. Modern Rheumatology Journal. 28–28. 3 indexed citations
20.
Papadopoulou, Charalampia, Mikhail M. Kostik, Marek Böhm, et al.. (2013). Methotrexate Therapy May Prevent the Onset of Uveitis in Juvenile Idiopathic Arthritis. The Journal of Pediatrics. 163(3). 879–884. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Denise Pires Marafon Breakdown of academic impact, for papers by Ryoki Hara Breakdown of academic impact, for papers by Luciana Breda Breakdown of academic impact, for papers by Jasmin Kümmerle‐Deschner Breakdown of academic impact, for papers by M. Gattinara Breakdown of academic impact, for papers by Ilaria Pagnini Breakdown of academic impact, for papers by R M Laxer Breakdown of academic impact, for papers by A M Prieur Breakdown of academic impact, for papers by Selcan Demir Breakdown of academic impact, for papers by Isabelle Melki
Rankless by CCL
2026